分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Agonal cell resuscitation strategy to promote tissue repair

Huang Zhenxiang, Wang Qingqing, Chen Yiyu, Zhu Jiahao, Xu Jiachen, Yang Yang, Wang Yongcheng, Yang Ke, Yan Huige, Li Mobai, Yang Anlan, Shangguan Liqing, Gu Chenhui, Fan Shunwu, Chen Pengfei, Lin Xianfeng

Journal:Nature Communications

IF:18.1

DOI:10.1038/s41467-026-71653-z

PMID:

Published:2026-04-11

research field:细胞生物学炎症研究再生医学分子治疗纳米医学

Abstract

Overactive lytic regulated cell death (RCD) causes excessive inflammation and impairs tissue repair. Current strategies rely on small-molecule inhibitors targeting the initiation of lytic RCD but these show off-target effects and reduced pro-repair factor release. During lytic RCD, a transitional agonal stage exists between initiation and terminal death, during which cells either proceed to terminal death or undergo resuscitation. Here, we found that agonal cells actively upregulated uptake of extracellular vesicles (EVs), and internalised EVs fused with the plasma membrane via SNARE complexes to enhance membrane repair. We demonstrated that enhancing the membrane repair capacity of agonal cells through artificially prepared EV-mimetic nano-platelet vesicles (NPVs) effectively promoted their resuscitation. Moreover, resuscitated cells secreted substantial amounts of prostaglandin E2 and N1-Acetylspermidine to further promote tissue repair. Our therapeutic strategy for lytic RCD-related delayed tissue repair is based on EV-mediated membrane repair and aims to establish a pro-regenerative niche using NPVs that can drive agonal cell resuscitation. During lytic regulated cell death, a transitional agonal stage exists between initiation and terminal death. Here, the authors found that agonal cells upregulated uptake and internalization of extracellular vesicles fused with the cell membrane via SNARE complexes to enhance membrane repair.

本文使用的Yeasen产品

购物车
客服
转染试用